Connect with us

Biotechnology

Global Business Forum on Latin America 2019 Concludes With Call to Capitalise on Untapped Business Opportunities

Betty Tűndik

Published

on

Panelists discuss business prospects during GBF Latin America 2019 in Panama City
Reading Time: 2 minutes

 

The third edition of the Global Business Forum (GBF) on Latin America concluded yesterday (April 10th) in Panama City with a call from government and business leaders to capitalise on new trade and investment opportunities that are emerging in the Latin America and Caribbean (LAC) and Arabian Gulf regions.

A total of 800 delegates from 50 countries attended GBF Latin America – Panama 2019, including heads of state, ministers, top government officials, policymakers and business leaders, while 300 bilateral business meetings were held on the sidelines of the event. The two-day forum identified sectors where businesses in the Arabian Gulf and LAC regions can expand their cooperation, namely food security and agri-business, finance and fintech, trade, tourism, and renewable energy.

Held under the theme “Next Hubs, New Regions”, the two-day forum featured 17 sessions and 46 speakers. Among the high-level attendees and speakers were H.E. Juan Carlos Varela, President of Panama; H.E. Jovenel Moise, President of Haiti; H.E Isabel de Saint Malo, Panama’s Vice President and Minister of Foreign Affairs, in addition to several ministers, top government officials and business leaders from the UAE, Panamá, Haiti, USA, Brazil, Argentina, Colombia, México, Uruguay, Jamaica, Dominican Republic, Honduras, Ecuador and Paraguay.

During the forum, the Panamanian President called on Panamanian’s public and private sector players to participate in Expo 2020 Dubai which he described as an ideal opportunity for Panama to showcase the potential it can offer the world. The Haitian President stated that his country is focused on developing its infrastructure, improving connectivity, and investing in several sectors, such as agriculture, renewable energy and healthcare, adding that these are all areas where it is looking to expand its cooperation with the UAE and other countries.

H.E. Hamad Buamim, President & CEO of Dubai Chamber of Commerce & Industry said: “The third edition of GBF Latin America achieved its objectives of exploring new business prospects between the LAC and Arabian Gulf regions, fostering constructive dialogue between business communities on both sides, and paving the way for long-lasting partnerships. We see the strong participation in the event as a a positive sign of growing confidence in Dubai as a preferred hub for Latin American companies.”

 

SOURCE: Dubai Chamber

Hi everyone! Nice to e-meet you! Here are a few things you should know about me.


I am a conscientious, open minded, adaptable to new experiences and ambitious Business Development Manager with a Bachelor's Degree in Economics - Banking, Finance and Accountancy. Through my studies I've also obtained many naturopathic and nutrition degrees as well. Part-time jobs have added marketing, network marketing, event management and store management skills to my experience through my career.


Through my career I have also been a Hotel Manager and owned a Bar/Restaurant & Internet Cafe. My online marketing and social media interactivity experience was gained when me and my husband started a business with an online/organic webshop & healthy lifestyle consultancy.


I've improved my English at Cambridge Academy of English - 2003, in Cambridge. I live a conscious lifestyle, and try to protect the ecosystem. Animal lover and capable of helping others without judgement or negative reactions, this is thanked to my knowledge in holistic therapies and the naturopathy courses I've followed.


I cannot leave far my spiritual growth and the continuous development in alternative and holistic therapies, so I'm learning at Kyron School of New Consciousness, receiving a Bio Energo-therapist diploma.


Thanks to all my experiences I've decided to venture into publishing and writting, while also continuing to learn many new things daily. I hope you enjoy reading my hand picked PICANTE News and check back for my weekly articles. You can find my articles and news digests in the following categories:


FOOD & BEVERAGES, ANIMALS/PETS, ANIMAL WELFARE, CANNABIS, ENTERTAINMENT, HEALTH CARE/HOSPITALS, CONSUMER & COSMETICS, ART, HEALTH AND LIFESTYLE, ALTERNATIVE ENERGIES, BEVERAGES, ALTERNATIVE MEDICINE, COSMETICS AND PERSONAL CARE, AGRICULTURE, and many more.



You can get in touch to discuss interviews or possible article submissions by contacting us.


Let's also connect via social media! You can find me on LinkedIn and Twitter.

Advertisement
Comments

Asia

China based innovation, CDMOs and Parallel Approvals driving huge growth in manufacturing at CPhI China

Betty Tűndik

Published

on

Reading Time: 3 minutes

 

Significant increase in exhibitors driven by bio growth at bioLIVE and separate nutraceuticals event.

CPhI & P-MEC China (#CPhIChina and #PMECChina) – co-organized by UBM EMEA, CCCMHPIE, and UBM Sinoexpo – takes place at the Shanghai New International Expo Center (SNIEC) on 18-20 June 2019. The event will be co-located with ICSE, InnoPack, bioLIVE, NEX, Labworld, FDF, and EP & Clean Tech. Seen as the bellwether of pharmaceutical trends across the country, CPhI & P-MEC China’s agenda is packed with content from over 100 onsite conferences and activities as well as more than 50 seminars, with speakers from China and abroad.

One of the key trends to emerge this year is the rise in the number of innovative China-based biotechs – coupled with the easing of regulatory pathways and an emerging CDMO sector – is fueling a significant growth in manufacturing across China. In view of this, experts at the event will assess the Marketing Authorization Holder (MAH) Pilot Program, as well as recent reforms of China’s regulatory landscape and the opportunities for international pharma.

With the Chinese pharma growing at a ferocious pace, CPhI & P-MEC China is expected to welcome 50,000 attendees in its 19th edition – a year-on-year increase of 30% – which is further indicative of the buoyancy of the Chinese market. The event is also expected to see a 6% increase in exhibitors, with more than 3,200 from over 120 countries in attendance.

“China is issuing new guidelines at a feverish pace and will be harmonized with ICH very quickly. The result is that over the next two to three years’ poorer quality manufacturers will drop out of the market and China’s manufacturers will look to compete in international markets as well as domestic” CPhI Annual Report Expert, Bikash Chatterjee on outlook of 2019.

Wider market data also supports this ongoing boom, with China’s pharmaceutical market projected to grow strongly from 115.2bn USD in 2016 to 159.4bn USD by 2021 and 234.2bn USD by 2026. This represents a 10-year compound annual growth rate of 8.8% in local currency terms and 7.3% in US dollar terms. Similarly, bioprocessing in China has been on a trajectory of rapid growth, with a 39% growth in facilities, and total capacity is growing >8% annually, with biosimilars offering the largest growth potential.

At the 2019 edition, for the first time, CPhI & P-MEC China 2019 will launch bioLIVE – their new bioprocessing and manufacturing exhibition – which has evolved from the previous BioPh China and will run adjacent. This exposition is in response to the large molecule trend within the industry, and arrives at a particularly prominent moment. Within the last year, there has been a proliferation of biosimilars and double-digit approvals of biologics – as well as a host of investments taking place in contract services.

Marie Lagrenee, Brand Manager at CPhI & P-MEC China, commented: “The growth of the Chinese pharma economy has been exponential in recent years, with regulatory reforms spearheading the increased interest in the region from both domestic and international companies. With a bourgeoning CDMO sector and recent harmonization by ICH, it’s pivotal that events such as CPhI & P-MEC China provide a platform to drive growth, exchange new ideas and expedite new deals to help nurture this budding market.”

The third edition of China Pharma Week will take place alongside CPhI & P-MEC China on June 17-21 2019, focusing on Leadership, Business, Networking, Innovation, Recognition and Knowledge. Activities will include plant visits, a networking dinner, women in leadership forum, summits and the Innovation Gallery Tours, giving a deeper work floor insight and dedicated industry conferences on different sectors.

For more information, please visit the official website: www.cphi.com/china

Notes to editors
Notable features at CPhI China 2019 include:

  • Over 100 onsite conferences and activities with speakers from China and abroad, 50+ seminars
  • The renowned Matchmaking Service, an online matchmaking tool, which enables attendees to search for and arrange meetings with exhibitors prior to the show according to their business goals
  • The Innovation Gallery Tours will provide 2019 attendees with the latest insight into Functional and Insulin packaging solutions in the Chinese market as well as the opportunity to meet exhibitors
  • The Supplier Finder System, an interactive floor plan via dedicated screen, onsite visitors will be able to discover the location of existing or future business numbers, based on the search by a company name, product name or company’s stand number
  • CPhI TV will bring live interviews from the top companies on the show floor and live content onsite to get the best out of the show.

 

SOURCE: UBM Sinoexpo

Continue Reading

Biotechnology

Curcushine™ Enhances Beauty from Within Market

Betty Tűndik

Published

on

Curcushine™ Enhances Beauty from Within Market
Reading Time: 2 minutes

 

Lipofoods partners with Sphera on turmeric extract encapsulation

 Lipofoods SLU, introduces Curcushine™ microcapsules, a highly bioavailable microencapsulated curcumin for the beauty-from-within market. This innovative formulation is natural and vegan, with high solubility when dissolved in water. It has a neutral taste and can be readily incorporated into nutricosmetics and beauty drinks. The company will launch the product at Vitafoods Europe in Geneva on May 7-9, 2018, booth #K180.

Lipofoods created Curcushine microcapsules in collaboration with the Italian R&D company, Sphera Encapsulation S.R.L. Sphera is dedicated to the research and development of nano- and micro-encapsulation strategies. The collaboration will act through a licensing agreement to market this new, highly bioavailable and water-soluble microencapsulated curcumin source.

Creating a highly soluble turmeric ingredient is challenging. Most curcumin ingredients on the market are water-dispersible, rather than water-soluble. Sphera was able to overcome this challenge by developing an innovative technology that can turn hydrophobic active ingredients into soluble microcapsules via exclusive coating materials and processing.

“Sphera’s proprietary technology is key to fulfilling the increased demand for better-for-you products in new delivery systems,” says Gianni Zoccatelli, CEO of Sphera. “We are excited to partner with Lipofoods, a company committed to the development of innovative botanical solutions.”

“Partnering with Sphera is a strategic move that opens new opportunities for Lipofoods to launch advanced botanical formulations that have a cutting-edge advantage,” declares David Padro, Business Manager of Lipofoods. “Lipofoods is engaged in ongoing research into the anti-aging benefits and other health condition benefits of Curcushine microencapsulated curcumin, seeking out new markets and different food applications.”

The aging process is driven by the lifelong accumulation of molecular damages, mainly due to Reactive Oxygen Species (ROS) produced by mitochondria, as well as random errors in DNA replication. Measurement of ROS levels is a good predictor of oxidative stress and can be used to test the anti-oxidant properties in live cells.

Curcumin has been shown to delay skin aging by protecting skin’s structures and proteins — including collagen and elastin — from oxidative and inflammatory damage. The antioxidant properties of curcumin can reduce ROS in cells and eliminate the effects of advanced glycation species (AGEs) on the divergent regulation of gene expression of receptors.

The innovative delivery system transforms the curcumin into a highly bioavailable formulation using a completely natural encapsulant matrix that protects and embeds the curcumin. The increased bioavailability of Curcushine microcapsules can be attributed to the superior solubility in water due to the small dimension of the particles. The high solubility characteristic also allows easy incorporation of the product into all varieties of nutricosmetics and beauty drinks. The formulation is gluten-free, vegan, plant-based, and kosher- and halal-certified.

“Curcushine microcapsules provides anti-aging benefits and is suitable for multiple nutraceutical applications,” explains Isabel Gomez, Marketing Manager of Lipofoods. “We plan to showcase beauty gummies containing Curcushine microcapsules in our booth at Vitafoods and we will also perform live demos to demonstrate the product´s high solubility.”

 

SOURCE: Lipofoods

Continue Reading

Asia

Wuhan Lays Out Construction of Guanggu Nanda Health Industrial Park

Betty Tűndik

Published

on

Wuhan Lays Out Construction of Guanggu Nanda Health Industrial Park
Reading Time: 1 minute

 

Wuhan, capital city of central China’s Hubei province, has attracted ten major healthcare industry companies, including Taikang Group and China Biotech, to participate in building its Health Industrial Park.

The Health Industrial Park is being created with the goal of becoming a 100 billion yuan (about 15 billion U.S. dollars) hotspot of biomedicine, medical equipment, and healthcare by 2030, according to a local official at the ongoing First World Health Expo.

Wuhan‘s Jiangxia District, known as China Guanggu, or China’s “Optics Valley,” has formed a health-centered industrial cluster of bio-pharmaceutical, diagnostic equipment, and drug manufacturers. The planned Guanggu Health Industrial Park will cover 98.1 square kilometers.

Compared with Wuhan Guanggu Bio-City, which brings in revenue in excess of 100 billion yuan, the park will focus on the research and development of cutting-edge technologies in the fields of life and health while incubating key healthcare enterprises.

The Health Industry Park is positioned as a “production-research interaction” space which integrates R&D and manufacturing activities in harmony. The park will partner with Guanggu Bio-City to facilitate active industrial collaboration.

Jiangxia District will offer a preferential policy support package to health industry enterprises interested in the area, which will include financial services and R&D incentives.

Zhang Li, Jiangxia District mayor, said that Optics Valley Nanda Health Industrial Park would provide preferential policies and financial support to enterprises interested in the area. The value of a single-item policy fund is over 100 million yuan, or around 15 million U.S. dollars.

The Wuhan Health Industry Development Plan specifies that Guanggu Nanda Health Industry Park intends to introduce 100 enterprises over the next 10 years in building a 100 billion yuan-level center of business. 50,000 employees are projected to participate in establishing the fifth national industrial park in Wuhan, reaching an important milestone for Wuhan’s healthcare industry.

 

SOURCE: Wuhan Jiangxia District Government

 

Continue Reading

Font Resizer

Subscribe to PICANTE via Email

Enter your email address to subscribe to PICANTE and receive notifications of new posts by email.

Follow us on Facebook

Read more from our authors

Follow our Tweets

Trending

Please turn AdBlock off